Search Within

Shira Redlich

Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Executive Committee, Center for Hematologic Malignancies (8)
  5. GSK Faculty (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Ross Levine (8)
  2. Robert Bowman (6)
  3. Wenbin Xiao (6)
  4. Ines Fernandez Maestre (5)
  5. Michael Waarts (5)
  6. Richard Koche (5)

More People

Years
  1. 2024 (3)
  2. 2022 (1)
  3. 2021 (2)
  4. 2019 (1)
  5. 2017 (1)
Publications
  1. Cancer Discovery (3)
  2. Blood (2)
  3. Cancer Cell (1)
  4. Cell Stem Cell (1)
  5. Clinical Cancer Research (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Hematology (2)
  3. Cell Press (2)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
    Journal Article

    Bowman, R. L.; Dunbar, A. J.; Mishra, T.; Xiao, W.; Waarts, M. R.; Maestre, I. F.; Eisman, S. E.; Cai, L.; Mowla, S.; Shah, N.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • CRISPR dependency screens in primary hematopoietic stem cells identify KDM3B as a genotype-specific vulnerability in IDH2- and TET2-mutant cells
    Journal Article

    Waarts, M. R.; Mowla, S.; Boileau, M.; Martinez Benitez, A. R.; Sango, J.; Bagish, M.; Fernández-Maestre, I.; Shan, Y.; Eisman, S. E.; Park, Y. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Jak2(V617F) reversible activation shows its essential requirement in myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Bowman, R. L.; Park, Y. C.; O'Connor, K.; Izzo, F.; Myers, R. M.; Karzai, A.; Zaroogian, Z.; Kim, W. J.; Fernandez-Maestre, I.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Multi-recombinase mouse models of FLT3-driven leukemia identifies distinct trajectories of mutational cooperativity and leukemic transformation
    Meeting Abstract

    Bowman, R. L.; Mishra, T.; Eisman, S. E.; Cai, L.; Xiao, W.; Waarts, M. R.; Sanchez Vela, P.; Fernández-Maestre, I.; Csete, I. S.; Potts, C. R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Therapeutic efficacy of combined JAK1/2, pan-PIM, and CDK4/6 inhibition in myeloproliferative neoplasms
    Journal Article

    Rampal, R. K.; Pinzon-Ortiz, M.; Hanasoge Somasundara, A. V.; Durham, B.; Koche, R.; Spitzer, B.; Mowla, S.; Krishnan, A.; Li, B.; An, W.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Cohesin members STAG1 and STAG2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation
    Journal Article

    Viny, A. D.; Bowman, R. L.; Liu, Y.; Lavallée, V. P.; Eisman, S. E.; Xiao, W.; Durham, B. H.; Navitski, A.; Park, J.; Braunstein, S.; more...
    Cell Stem Cell (2019)

    Fulltext@MSK | Save
  • Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers
    Journal Article

    Glass, J. L.; Hassane, D.; Wouters, B. J.; Kunimoto, H.; Avellino, R.; Garrett-Bakelman, F. E.; Guryanova, O. A.; Bowman, R.; Redlich, S.; Intlekofer, A. M.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save